PYX的个人主页 - 老虎社区

PYX

暂无个人介绍

IP属地：未知

430关注

11粉丝

0主题

0勋章

2021-12-16

Like

抱歉，原内容已删除

2021-12-23

Like

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>

2021-08-14

Like pls

Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote>

2021-11-19

like

Inflation has ‘further to go:’ Goldman Sachs<blockquote>高盛：通胀“还有更长的路要走”</blockquote>

2021-09-25

like

抱歉，原内容已删除

2021-08-16

Like pls

抱歉，原内容已删除

2021-12-03

Like

抱歉，原内容已删除

2021-10-11

Like

抱歉，原内容已删除

2021-09-09

like

抱歉，原内容已删除

2021-09-06

Like

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3585470066266483","uuid":"3585470066266483","gmtCreate":1622376043228,"gmtModify":1622376043228,"name":"PYX","pinyin":"pyx","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":430,"tweetSize":128,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.11","exceedPercentage":"93.61%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.27","exceedPercentage":"60.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":696396783,"gmtCreate":1640615387749,"gmtModify":1640615427783,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696396783","repostId":"1185167492","repostType":4,"repost":{"id":"1185167492","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640609888,"share":"https://www.laohu8.com/m/news/1185167492?lang=zh_CN&edition=full","pubTime":"2021-12-27 20:58","market":"us","language":"en","title":"Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1185167492","media":"Tiger Newspress","summary":"U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Om","content":"<p>U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.</p><p><blockquote>在大型企业的提振下，美国股指期货周一小幅走高，而数百起奥密克戎导致的航班取消事件让投资者在今年最后一个交易周开始时感到紧张。</blockquote></p><p> Travel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.</p><p><blockquote>由于COVID-19病例激增迫使圣诞节周末旅行者改变计划，美国航空公司周日连续第三天取消了许多航班，通常对冠状病毒新闻敏感的旅游相关股票下跌。</blockquote></p><p> The S&amp;P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.</p><p><blockquote>标普500周四收于历史新高，与Omicron冠状病毒变种相关的乐观消息安抚了投资者对这种高传染性菌株在本月早些时候颠覆市场后对经济影响的紧张情绪。</blockquote></p><p> Wall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&amp;P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.</p><p><blockquote>华尔街三大主要股指有望连续第三年上涨，基准标普500(.SPX)今年收盘有望上涨25.8%。道琼斯指数预计上涨17.5%，而纳斯达克预计上涨21.4%。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&amp;P 500 e-minis were up 15.50 points, or 0.33%.</p><p><blockquote>截至美国东部时间上午8:00，道琼斯电子迷你指数上涨72点，涨幅0.20%，标普500电子迷你指数上涨15.50点，涨幅0.33%。</blockquote></p><p> Nasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.</p><p><blockquote>纳斯达克100 e-mini上涨70.00点，即0.43%，大型企业特斯拉公司(TSLA.O)和微软公司(MSFT.O)和Meta Platform(FB.O)坚挺0.5%至1%。航空股——由于人员配备问题，周末取消航班激增，主要航空公司的股价在盘前下跌。联合航空(UAL)下跌1.8%，美国航空(AAL)下跌1.4%，达美航空(DAL)下跌1%，西南航空(LUV)下跌1.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09541de8c4bcd965c62dbe3f6b7f6bc5\" tg-width=\"649\" tg-height=\"205\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p><p><blockquote><p class=\"t-img-caption\"><span>*来源自Tiger Trade，美国东部时间08:00</span></p></blockquote></p><p> <b>Stocks making the biggest moves premarket</b></p><p><blockquote><b>盘前涨幅最大的股票</b></blockquote></p><p> Cruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.</p><p><blockquote>邮轮公司股票——嘉年华(CCL)和皇家加勒比(RCL)运营的船舶上周爆发三次Covid-19疫情后，主要邮轮公司的股票在盘前交易中下跌。嘉年华盘前下跌2.2%，皇家加勒比下跌1.9%，挪威邮轮控股(NCLH)下跌1.6%。</blockquote></p><p> Grab（GRAB）–&nbsp;Grab stock climbed more than 7% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p><p><blockquote>Grab(GRAB)-Grab股价在盘前交易中上涨超过7%，华尔街认为亚洲科技巨头Grab在首次亮相令人失望后有巨大上涨空间。</blockquote></p><p> GoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.</p><p><blockquote>GoDaddy(GDDY)——《华尔街日报》报道激进投资者Starboard Value持有互联网域名注册公司6.5%的股份后，GoDaddy在盘前股价上涨3.9%。</blockquote></p><p> Apple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.</p><p><blockquote>苹果（AAPL）——荷兰最高竞争监管机构援引苹果的话说，该公司违反了竞争法，并下令改变苹果的应用商店支付政策。苹果表示将对裁决提出上诉。</blockquote></p><p> Cigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.</p><p><blockquote>Cigna(CI)——根据SEC提交的文件，该保险公司将在即将举行的投资者会议上重申其2021年和2022年的盈利指引。Cigna预计2021年调整后每股收益至少为20.35美元，预计2022年增长至少10%。</blockquote></p><p> Moderna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.</p><p><blockquote>Moderna(MRNA)——据英国《金融时报》报道，该制药商正在反对股东向较贫穷国家开放其疫苗技术的提议。该提案要求评级Moderna解释为什么鉴于其获得的政府财政支持金额，其价格如此之高。Moderna盘前下跌2%。</blockquote></p><p> Avis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.</p><p><blockquote>Avis Budget(CAR)——这家汽车租赁公司的股价继周四上涨3.2%后，在盘前交易中上涨2.6%。根据旅游公司Kayak的数据，平均日租金为每天81美元。这比一年前增长了31%。</blockquote></p><p> Didi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.</p><p><blockquote>滴滴出行(DIDI)——英国《金融时报》报道称，这家总部位于中国的网约车公司正在无限期阻止员工出售股票，滴滴出行盘前下跌1.3%。此前，该公司已在美国退市。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-27 20:58</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.</p><p><blockquote>在大型企业的提振下，美国股指期货周一小幅走高，而数百起奥密克戎导致的航班取消事件让投资者在今年最后一个交易周开始时感到紧张。</blockquote></p><p> Travel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.</p><p><blockquote>由于COVID-19病例激增迫使圣诞节周末旅行者改变计划，美国航空公司周日连续第三天取消了许多航班，通常对冠状病毒新闻敏感的旅游相关股票下跌。</blockquote></p><p> The S&amp;P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.</p><p><blockquote>标普500周四收于历史新高，与Omicron冠状病毒变种相关的乐观消息安抚了投资者对这种高传染性菌株在本月早些时候颠覆市场后对经济影响的紧张情绪。</blockquote></p><p> Wall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&amp;P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.</p><p><blockquote>华尔街三大主要股指有望连续第三年上涨，基准标普500(.SPX)今年收盘有望上涨25.8%。道琼斯指数预计上涨17.5%，而纳斯达克预计上涨21.4%。</blockquote></p><p> At 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&amp;P 500 e-minis were up 15.50 points, or 0.33%.</p><p><blockquote>截至美国东部时间上午8:00，道琼斯电子迷你指数上涨72点，涨幅0.20%，标普500电子迷你指数上涨15.50点，涨幅0.33%。</blockquote></p><p> Nasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.</p><p><blockquote>纳斯达克100 e-mini上涨70.00点，即0.43%，大型企业特斯拉公司(TSLA.O)和微软公司(MSFT.O)和Meta Platform(FB.O)坚挺0.5%至1%。航空股——由于人员配备问题，周末取消航班激增，主要航空公司的股价在盘前下跌。联合航空(UAL)下跌1.8%，美国航空(AAL)下跌1.4%，达美航空(DAL)下跌1%，西南航空(LUV)下跌1.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09541de8c4bcd965c62dbe3f6b7f6bc5\" tg-width=\"649\" tg-height=\"205\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p><p><blockquote><p class=\"t-img-caption\"><span>*来源自Tiger Trade，美国东部时间08:00</span></p></blockquote></p><p> <b>Stocks making the biggest moves premarket</b></p><p><blockquote><b>盘前涨幅最大的股票</b></blockquote></p><p> Cruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.</p><p><blockquote>邮轮公司股票——嘉年华(CCL)和皇家加勒比(RCL)运营的船舶上周爆发三次Covid-19疫情后，主要邮轮公司的股票在盘前交易中下跌。嘉年华盘前下跌2.2%，皇家加勒比下跌1.9%，挪威邮轮控股(NCLH)下跌1.6%。</blockquote></p><p> Grab（GRAB）–&nbsp;Grab stock climbed more than 7% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p><p><blockquote>Grab(GRAB)-Grab股价在盘前交易中上涨超过7%，华尔街认为亚洲科技巨头Grab在首次亮相令人失望后有巨大上涨空间。</blockquote></p><p> GoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.</p><p><blockquote>GoDaddy(GDDY)——《华尔街日报》报道激进投资者Starboard Value持有互联网域名注册公司6.5%的股份后，GoDaddy在盘前股价上涨3.9%。</blockquote></p><p> Apple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.</p><p><blockquote>苹果（AAPL）——荷兰最高竞争监管机构援引苹果的话说，该公司违反了竞争法，并下令改变苹果的应用商店支付政策。苹果表示将对裁决提出上诉。</blockquote></p><p> Cigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.</p><p><blockquote>Cigna(CI)——根据SEC提交的文件，该保险公司将在即将举行的投资者会议上重申其2021年和2022年的盈利指引。Cigna预计2021年调整后每股收益至少为20.35美元，预计2022年增长至少10%。</blockquote></p><p> Moderna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.</p><p><blockquote>Moderna(MRNA)——据英国《金融时报》报道，该制药商正在反对股东向较贫穷国家开放其疫苗技术的提议。该提案要求评级Moderna解释为什么鉴于其获得的政府财政支持金额，其价格如此之高。Moderna盘前下跌2%。</blockquote></p><p> Avis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.</p><p><blockquote>Avis Budget(CAR)——这家汽车租赁公司的股价继周四上涨3.2%后，在盘前交易中上涨2.6%。根据旅游公司Kayak的数据，平均日租金为每天81美元。这比一年前增长了31%。</blockquote></p><p> Didi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.</p><p><blockquote>滴滴出行(DIDI)——英国《金融时报》报道称，这家总部位于中国的网约车公司正在无限期阻止员工出售股票，滴滴出行盘前下跌1.3%。此前，该公司已在美国退市。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185167492","content_text":"U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.\nTravel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.\nThe S&P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.\nWall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.\nAt 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&P 500 e-minis were up 15.50 points, or 0.33%.\nNasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.\n*Source From Tiger Trade, EST 08:00\nStocks making the biggest moves premarket\nCruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.\nGrab（GRAB）– Grab stock climbed more than 7% in premarket trading as Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.\nGoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.\n\nApple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.\n\nCigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.\n\nModerna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.\n\nAvis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.\n\nDidi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":2811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698730955,"gmtCreate":1640530407076,"gmtModify":1640530407262,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698730955","repostId":"2193178197","repostType":4,"isVote":1,"tweetType":1,"viewCount":3184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698537989,"gmtCreate":1640443505847,"gmtModify":1640443506000,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698537989","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":3763,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698938142,"gmtCreate":1640272994312,"gmtModify":1640273005807,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/698938142","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=zh_CN&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">SeattleTimes</strong><span class=\"h-time small\">2021-12-23 22:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">SeattleTimes</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691687550,"gmtCreate":1640184305762,"gmtModify":1640184305918,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691687550","repostId":"1116490738","repostType":4,"isVote":1,"tweetType":1,"viewCount":3175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693680780,"gmtCreate":1640013083372,"gmtModify":1640013083528,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693680780","repostId":"1115322314","repostType":4,"repost":{"id":"1115322314","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640011665,"share":"https://www.laohu8.com/m/news/1115322314?lang=zh_CN&edition=full","pubTime":"2021-12-20 22:47","market":"us","language":"en","title":"Mega-cap growth stocks extended their fall from the previous session<blockquote>大型成长股延续前一交易日跌势</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115322314","media":"Tiger Newspress","summary":"Mega-cap growth stocks extended their fall from the previous session, with Apple, Meta Platforms and","content":"<p>Mega-cap growth stocks extended their fall from the previous session, with&nbsp;Apple, Meta Platforms&nbsp;and Microsoft Corp&nbsp;down between 1% and 3%.</p><p><blockquote>大型成长股较前一交易日延续跌势，苹果、Meta Platforms和微软下跌1%至3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bcbe2eb85bd02485d4f915039e5a7c33\" tg-width=\"709\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mega-cap growth stocks extended their fall from the previous session<blockquote>大型成长股延续前一交易日跌势</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMega-cap growth stocks extended their fall from the previous session<blockquote>大型成长股延续前一交易日跌势</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-20 22:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Mega-cap growth stocks extended their fall from the previous session, with&nbsp;Apple, Meta Platforms&nbsp;and Microsoft Corp&nbsp;down between 1% and 3%.</p><p><blockquote>大型成长股较前一交易日延续跌势，苹果、Meta Platforms和微软下跌1%至3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bcbe2eb85bd02485d4f915039e5a7c33\" tg-width=\"709\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","FB":"ProShares S&P 500 Dynamic Buffer ETF","MSFT":"微软","AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115322314","content_text":"Mega-cap growth stocks extended their fall from the previous session, with Apple, Meta Platforms and Microsoft Corp down between 1% and 3%.","news_type":1,"symbols_score_info":{"FB":0.9,"AAPL":0.9,"AMZN":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":2951,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699510650,"gmtCreate":1639836722556,"gmtModify":1639836722839,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699510650","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=zh_CN&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-18 07:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699115237,"gmtCreate":1639755443534,"gmtModify":1639755443690,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699115237","repostId":"2192597562","repostType":4,"isVote":1,"tweetType":1,"viewCount":3330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690218330,"gmtCreate":1639669041402,"gmtModify":1639669041593,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/690218330","repostId":"2191453039","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607477225,"gmtCreate":1639582796795,"gmtModify":1639582796988,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607477225","repostId":"2191956629","repostType":4,"isVote":1,"tweetType":1,"viewCount":4063,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607109883,"gmtCreate":1639494305960,"gmtModify":1639494306153,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607109883","repostId":"1199342811","repostType":4,"repost":{"id":"1199342811","kind":"news","pubTimestamp":1639494013,"share":"https://www.laohu8.com/m/news/1199342811?lang=zh_CN&edition=full","pubTime":"2021-12-14 23:00","market":"us","language":"en","title":"AMC, GameStop short sellers make a comeback as meme stocks buckle<blockquote>随着模因股票暴跌，AMC和游戏驿站卖空者卷土重来</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199342811","media":"Reuters","summary":"Shares of AMC Entertainment and GameStop dropped further in early trading on Tuesday, extending declines that have helped short sellers recover more than $1 billion in losses in December.Both companies were at the heart of the meme stocks phenomenon earlier this year, when individual investors coordinated on online message boards to fuel stunning rallies that cost short sellers billions of dollars.Theater chain AMC dropped 8% to a new 7-month low at $21.31 and were on track for a fourth day of l","content":"<p>Shares of AMC Entertainment and GameStop dropped further in early trading on Tuesday, extending declines that have helped short sellers recover more than $1 billion in losses in December.</p><p><blockquote>AMC院线和游戏驿站的股价在周二早盘交易中进一步下跌，延续了帮助卖空者挽回去年12月逾10亿美元损失的跌势。</blockquote></p><p> Both companies were at the heart of the meme stocks phenomenon earlier this year, when individual investors coordinated on online message boards to fuel stunning rallies that cost short sellers billions of dollars.</p><p><blockquote>今年早些时候，这两家公司都是模因股票现象的核心，当时个人投资者在在线留言板上进行协调，推动了惊人的反弹，导致卖空者损失了数十亿美元。</blockquote></p><p> Theater chain AMC dropped 8% to a new 7-month low at $21.31 and were on track for a fourth day of losses, while videogame retailer GameStop shed 4.3% to $131 - its lowest level since March.</p><p><blockquote>连锁影院AMC股价下跌8%，至21.31美元，创7个月新低，有望连续第四天下跌，而视频游戏零售商游戏驿站股价下跌4.3%，至131美元，为3月份以来的最低水平。</blockquote></p><p> Short-sellers have made $1.1 billion on their positions on AMC stock since the beginning of December, according to data from analytics firm Ortex. GameStop short-sellers have made $330 million since the start of the month. Both stocks have lost nearly a third of their value in December.</p><p><blockquote>根据分析公司Ortex的数据，自12月初以来，卖空者已从AMC股票头寸中获利11亿美元。自本月初以来，游戏驿站卖空者已获利3.3亿美元。这两只股票在12月份都损失了近三分之一的价值。</blockquote></p><p> Still, so far this year, bearish investors have lost $1.3 billion on their bets on AMC and $11.78 billion in GameStop as their shares have rallied about 1,000% and 600% year-to-date, respectively.</p><p><blockquote>尽管如此，今年到目前为止，看跌投资者对AMC的押注损失了13亿美元，对游戏驿站的押注损失了117.8亿美元，因为它们的股价今年迄今分别上涨了约1,000%和600%。</blockquote></p><p> The estimated short interest at AMC increased to 19% of its free float from 16% at the end of November, per Ortex data. GameStop short interest has shot up to 14% from 11% in the same period.</p><p><blockquote>根据Ortex数据，AMC的估计空头利息占其自由流通量的比例从11月底的16%增至19%。游戏驿站空头利息从同期的11%飙升至14%。</blockquote></p><p> Insider selling at AMC last week added to worries over the Omicron coronavirus variant denting a recovery in theater attendance.</p><p><blockquote>AMC上周的内幕抛售加剧了人们对奥密克戎冠状病毒变种削弱影院上座率复苏的担忧。</blockquote></p><p> Retail traders were net sellers of equities for the first time since March 2021 in the week leading up to Dec. 8 in the largest outflow since Sep 2020, J.P.Morgan data showed last week.</p><p><blockquote>摩根大通上周的数据显示，截至12月8日的一周，散户交易员自2021年3月以来首次成为股票净卖家，这是自2020年9月以来最大的资金流出。</blockquote></p><p> Sam Stovall, chief investment strategist at CFRA Research, said AMC investors are worried about the reopening trade, with comments from the UK that Omicron infections could become a tidal wave weighing on the sentiment.</p><p><blockquote>CFRA Research首席投资策略师Sam Stovall表示，AMC投资者对重新开放交易感到担忧，来自英国的评论称，奥密克戎感染可能会成为打压市场情绪的浪潮。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC, GameStop short sellers make a comeback as meme stocks buckle<blockquote>随着模因股票暴跌，AMC和游戏驿站卖空者卷土重来</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC, GameStop short sellers make a comeback as meme stocks buckle<blockquote>随着模因股票暴跌，AMC和游戏驿站卖空者卷土重来</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-14 23:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Shares of AMC Entertainment and GameStop dropped further in early trading on Tuesday, extending declines that have helped short sellers recover more than $1 billion in losses in December.</p><p><blockquote>AMC院线和游戏驿站的股价在周二早盘交易中进一步下跌，延续了帮助卖空者挽回去年12月逾10亿美元损失的跌势。</blockquote></p><p> Both companies were at the heart of the meme stocks phenomenon earlier this year, when individual investors coordinated on online message boards to fuel stunning rallies that cost short sellers billions of dollars.</p><p><blockquote>今年早些时候，这两家公司都是模因股票现象的核心，当时个人投资者在在线留言板上进行协调，推动了惊人的反弹，导致卖空者损失了数十亿美元。</blockquote></p><p> Theater chain AMC dropped 8% to a new 7-month low at $21.31 and were on track for a fourth day of losses, while videogame retailer GameStop shed 4.3% to $131 - its lowest level since March.</p><p><blockquote>连锁影院AMC股价下跌8%，至21.31美元，创7个月新低，有望连续第四天下跌，而视频游戏零售商游戏驿站股价下跌4.3%，至131美元，为3月份以来的最低水平。</blockquote></p><p> Short-sellers have made $1.1 billion on their positions on AMC stock since the beginning of December, according to data from analytics firm Ortex. GameStop short-sellers have made $330 million since the start of the month. Both stocks have lost nearly a third of their value in December.</p><p><blockquote>根据分析公司Ortex的数据，自12月初以来，卖空者已从AMC股票头寸中获利11亿美元。自本月初以来，游戏驿站卖空者已获利3.3亿美元。这两只股票在12月份都损失了近三分之一的价值。</blockquote></p><p> Still, so far this year, bearish investors have lost $1.3 billion on their bets on AMC and $11.78 billion in GameStop as their shares have rallied about 1,000% and 600% year-to-date, respectively.</p><p><blockquote>尽管如此，今年到目前为止，看跌投资者对AMC的押注损失了13亿美元，对游戏驿站的押注损失了117.8亿美元，因为它们的股价今年迄今分别上涨了约1,000%和600%。</blockquote></p><p> The estimated short interest at AMC increased to 19% of its free float from 16% at the end of November, per Ortex data. GameStop short interest has shot up to 14% from 11% in the same period.</p><p><blockquote>根据Ortex数据，AMC的估计空头利息占其自由流通量的比例从11月底的16%增至19%。游戏驿站空头利息从同期的11%飙升至14%。</blockquote></p><p> Insider selling at AMC last week added to worries over the Omicron coronavirus variant denting a recovery in theater attendance.</p><p><blockquote>AMC上周的内幕抛售加剧了人们对奥密克戎冠状病毒变种削弱影院上座率复苏的担忧。</blockquote></p><p> Retail traders were net sellers of equities for the first time since March 2021 in the week leading up to Dec. 8 in the largest outflow since Sep 2020, J.P.Morgan data showed last week.</p><p><blockquote>摩根大通上周的数据显示，截至12月8日的一周，散户交易员自2021年3月以来首次成为股票净卖家，这是自2020年9月以来最大的资金流出。</blockquote></p><p> Sam Stovall, chief investment strategist at CFRA Research, said AMC investors are worried about the reopening trade, with comments from the UK that Omicron infections could become a tidal wave weighing on the sentiment.</p><p><blockquote>CFRA Research首席投资策略师Sam Stovall表示，AMC投资者对重新开放交易感到担忧，来自英国的评论称，奥密克戎感染可能会成为打压市场情绪的浪潮。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/amc-gamestop-short-sellers-comeback-144659441.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","GME":"游戏驿站"},"source_url":"https://finance.yahoo.com/news/amc-gamestop-short-sellers-comeback-144659441.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199342811","content_text":"Shares of AMC Entertainment and GameStop dropped further in early trading on Tuesday, extending declines that have helped short sellers recover more than $1 billion in losses in December.\nBoth companies were at the heart of the meme stocks phenomenon earlier this year, when individual investors coordinated on online message boards to fuel stunning rallies that cost short sellers billions of dollars.\nTheater chain AMC dropped 8% to a new 7-month low at $21.31 and were on track for a fourth day of losses, while videogame retailer GameStop shed 4.3% to $131 - its lowest level since March.\nShort-sellers have made $1.1 billion on their positions on AMC stock since the beginning of December, according to data from analytics firm Ortex. GameStop short-sellers have made $330 million since the start of the month. Both stocks have lost nearly a third of their value in December.\nStill, so far this year, bearish investors have lost $1.3 billion on their bets on AMC and $11.78 billion in GameStop as their shares have rallied about 1,000% and 600% year-to-date, respectively.\nThe estimated short interest at AMC increased to 19% of its free float from 16% at the end of November, per Ortex data. GameStop short interest has shot up to 14% from 11% in the same period.\nInsider selling at AMC last week added to worries over the Omicron coronavirus variant denting a recovery in theater attendance.\nRetail traders were net sellers of equities for the first time since March 2021 in the week leading up to Dec. 8 in the largest outflow since Sep 2020, J.P.Morgan data showed last week.\nSam Stovall, chief investment strategist at CFRA Research, said AMC investors are worried about the reopening trade, with comments from the UK that Omicron infections could become a tidal wave weighing on the sentiment.","news_type":1,"symbols_score_info":{"AMC":0.9,"GME":0.9}},"isVote":1,"tweetType":1,"viewCount":876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604590301,"gmtCreate":1639408517400,"gmtModify":1639409342290,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604590301","repostId":"1189054531","repostType":4,"repost":{"id":"1189054531","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406050,"share":"https://www.laohu8.com/m/news/1189054531?lang=zh_CN&edition=full","pubTime":"2021-12-13 22:34","market":"us","language":"en","title":"U.S. stocks open softer to kick off second full week of December ahead of Fed meeting<blockquote>美联储会议前美国股市开盘走软，开启12月第二整周</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189054531","media":"Tiger Newspress","summary":"The S&P 500 was steady on Monday after the index notched its best week since February and a fresh re","content":"<p>The S&amp;P 500 was steady on Monday after the index notched its best week since February and a fresh record close, rebounding from a big sell-off triggered by fears of the omicron coronavirus variant.</p><p><blockquote>周一，标普500保持稳定，此前该指数创下2月份以来最好的一周，并创下新的收盘纪录，从对omicron冠状病毒变种的担忧引发的大幅抛售中反弹。</blockquote></p><p> The S&amp;P 500 inched down 0.1% and sits about 0.8% from its intra-day record. The Dow Jones Industrial Average traded 30 points lower, or 0.1%. The technology-focused Nasdaq Composite was down 0.15%.</p><p><blockquote>标普500小幅下跌0.1%，较盘中纪录下跌约0.8%。道琼斯工业平均指数下跌30点，即0.1%。以科技股为主的纳斯达克综合指数下跌0.15%。</blockquote></p><p> Modernashares were among the strongest gainers Monday, rising 3% a day after the White House’s top infectious disease expert Dr. Anthony Faucicalled Covid booster shots “optimal care,”but said the definition of fully vaccinated would not change.</p><p><blockquote>Modernashares是周一涨幅最大的股票之一，在白宫顶级传染病专家Anthony Fauci博士称Covid加强注射为“最佳护理”后，一天上涨3%，但表示完全接种疫苗的定义不会改变。</blockquote></p><p> Elsewhere,Apple&nbsp;moved closer in its quest to become the market’s first $3 trillion company, gaining about 1% following an upgrade from JP Morgan.</p><p><blockquote>在其他方面，苹果在成为市场上第一家价值3万亿美元的公司方面更进一步，在摩根大通上调评级后上涨了约1%。</blockquote></p><p> Monday’s action followed a strong week on Wall Street as investors shrugged off&nbsp;a hot inflation reading. The blue-chip Dow gained 4% last week, breaking a four-week losing streak with its best weekly performance since March. The S&amp;P 500 and the Nasdaq Composite jumped 3.8% and 3.6%, respectively, last week, both posting their best weekly performance since early February.</p><p><blockquote>周一的行动是在华尔街经历了强劲的一周之后进行的，投资者对火爆的通胀数据不屑一顾。蓝筹股道指上周上涨4%，打破四周连跌，创3月以来最佳单周表现。标普500和纳斯达克综合指数上周分别上涨3.8%和3.6%，均创下2月初以来的最佳单周表现。</blockquote></p><p> Investors digested a jump in headline inflation data, which&nbsp;came in at 6.8% in November&nbsp;year-over-year for the biggest surge since 1982.&nbsp;The print was marginally higher than the 6.7% Dow Jones estimate.</p><p><blockquote>投资者消化了整体通胀数据的大幅上涨，11月份通胀数据同比增长6.8%，创1982年以来最大增幅。该数据略高于道琼斯6.7%的预期。</blockquote></p><p> “The fact is that inflation is likely to remain on the higher side for a while and risks of sticky inflation remain, although we believe that the passing of base effects and the easing of supply chain constraints by the end of the first quarter of next year should slowly bring inflation down to more comfortable levels,” Rick Rieder, BlackRock’s chief investment officer of global fixed income, said in a note.</p><p><blockquote>贝莱德全球固定收益首席投资官Rick Rieder在一份报告中表示：“事实是，通胀可能会在一段时间内保持较高水平，粘性通胀的风险依然存在，尽管我们认为明年第一季度末基数效应的过去和供应链限制的缓解应该会慢慢将通胀降至更舒适的水平。”</blockquote></p><p> The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p><p><blockquote>关键的通胀数据是在美联储本周举行为期两天的政策会议之前发布的，预计政策制定者将在会上讨论加快结束债券购买计划。</blockquote></p><p> Fed Chair Jerome Powell, as well as&nbsp;a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p><p><blockquote>美联储主席杰罗姆·鲍威尔以及一系列美联储发言人最近都表示，美联储可能会比目前的2022年6月时间表更早结束每月1200亿美元的债券购买计划。</blockquote></p><p> “We believe markets can continue to&nbsp;take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p><p><blockquote>马克·海菲尔表示：“我们相信，尽管额外的波动仍然是一个风险，但市场可以继续从容应对更高的通胀数据。由于美联储政策保持相对宽松，股市的背景仍然是积极的，我们看好全球增长的赢家。”瑞银全球财富管理首席投资官。</blockquote></p><p> Stocks bounced back last week as investors bet that the initial worry about the Covid strain is overblown. Many also took solace in thenews from Pfizer and BioNTechthat a study found three doses of their vaccine provides a high level of protection against the variant.</p><p><blockquote>上周股市反弹，因为投资者押注最初对新冠病毒株的担忧被夸大了。许多人还从辉瑞和BioNTech的消息中感到安慰，一项研究发现他们的三剂疫苗提供了针对该变种的高水平保护。</blockquote></p><p> As of Sunday, the&nbsp;U.S. was approaching&nbsp;800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p><p><blockquote>截至周日，美国。与冠状病毒相关的死亡人数接近80万。这种新变种促使一些政府官员恢复健康限制以减缓传播。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks open softer to kick off second full week of December ahead of Fed meeting<blockquote>美联储会议前美国股市开盘走软，开启12月第二整周</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks open softer to kick off second full week of December ahead of Fed meeting<blockquote>美联储会议前美国股市开盘走软，开启12月第二整周</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-13 22:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The S&amp;P 500 was steady on Monday after the index notched its best week since February and a fresh record close, rebounding from a big sell-off triggered by fears of the omicron coronavirus variant.</p><p><blockquote>周一，标普500保持稳定，此前该指数创下2月份以来最好的一周，并创下新的收盘纪录，从对omicron冠状病毒变种的担忧引发的大幅抛售中反弹。</blockquote></p><p> The S&amp;P 500 inched down 0.1% and sits about 0.8% from its intra-day record. The Dow Jones Industrial Average traded 30 points lower, or 0.1%. The technology-focused Nasdaq Composite was down 0.15%.</p><p><blockquote>标普500小幅下跌0.1%，较盘中纪录下跌约0.8%。道琼斯工业平均指数下跌30点，即0.1%。以科技股为主的纳斯达克综合指数下跌0.15%。</blockquote></p><p> Modernashares were among the strongest gainers Monday, rising 3% a day after the White House’s top infectious disease expert Dr. Anthony Faucicalled Covid booster shots “optimal care,”but said the definition of fully vaccinated would not change.</p><p><blockquote>Modernashares是周一涨幅最大的股票之一，在白宫顶级传染病专家Anthony Fauci博士称Covid加强注射为“最佳护理”后，一天上涨3%，但表示完全接种疫苗的定义不会改变。</blockquote></p><p> Elsewhere,Apple&nbsp;moved closer in its quest to become the market’s first $3 trillion company, gaining about 1% following an upgrade from JP Morgan.</p><p><blockquote>在其他方面，苹果在成为市场上第一家价值3万亿美元的公司方面更进一步，在摩根大通上调评级后上涨了约1%。</blockquote></p><p> Monday’s action followed a strong week on Wall Street as investors shrugged off&nbsp;a hot inflation reading. The blue-chip Dow gained 4% last week, breaking a four-week losing streak with its best weekly performance since March. The S&amp;P 500 and the Nasdaq Composite jumped 3.8% and 3.6%, respectively, last week, both posting their best weekly performance since early February.</p><p><blockquote>周一的行动是在华尔街经历了强劲的一周之后进行的，投资者对火爆的通胀数据不屑一顾。蓝筹股道指上周上涨4%，打破四周连跌，创3月以来最佳单周表现。标普500和纳斯达克综合指数上周分别上涨3.8%和3.6%，均创下2月初以来的最佳单周表现。</blockquote></p><p> Investors digested a jump in headline inflation data, which&nbsp;came in at 6.8% in November&nbsp;year-over-year for the biggest surge since 1982.&nbsp;The print was marginally higher than the 6.7% Dow Jones estimate.</p><p><blockquote>投资者消化了整体通胀数据的大幅上涨，11月份通胀数据同比增长6.8%，创1982年以来最大增幅。该数据略高于道琼斯6.7%的预期。</blockquote></p><p> “The fact is that inflation is likely to remain on the higher side for a while and risks of sticky inflation remain, although we believe that the passing of base effects and the easing of supply chain constraints by the end of the first quarter of next year should slowly bring inflation down to more comfortable levels,” Rick Rieder, BlackRock’s chief investment officer of global fixed income, said in a note.</p><p><blockquote>贝莱德全球固定收益首席投资官Rick Rieder在一份报告中表示：“事实是，通胀可能会在一段时间内保持较高水平，粘性通胀的风险依然存在，尽管我们认为明年第一季度末基数效应的过去和供应链限制的缓解应该会慢慢将通胀降至更舒适的水平。”</blockquote></p><p> The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p><p><blockquote>关键的通胀数据是在美联储本周举行为期两天的政策会议之前发布的，预计政策制定者将在会上讨论加快结束债券购买计划。</blockquote></p><p> Fed Chair Jerome Powell, as well as&nbsp;a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p><p><blockquote>美联储主席杰罗姆·鲍威尔以及一系列美联储发言人最近都表示，美联储可能会比目前的2022年6月时间表更早结束每月1200亿美元的债券购买计划。</blockquote></p><p> “We believe markets can continue to&nbsp;take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p><p><blockquote>马克·海菲尔表示：“我们相信，尽管额外的波动仍然是一个风险，但市场可以继续从容应对更高的通胀数据。由于美联储政策保持相对宽松，股市的背景仍然是积极的，我们看好全球增长的赢家。”瑞银全球财富管理首席投资官。</blockquote></p><p> Stocks bounced back last week as investors bet that the initial worry about the Covid strain is overblown. Many also took solace in thenews from Pfizer and BioNTechthat a study found three doses of their vaccine provides a high level of protection against the variant.</p><p><blockquote>上周股市反弹，因为投资者押注最初对新冠病毒株的担忧被夸大了。许多人还从辉瑞和BioNTech的消息中感到安慰，一项研究发现他们的三剂疫苗提供了针对该变种的高水平保护。</blockquote></p><p> As of Sunday, the&nbsp;U.S. was approaching&nbsp;800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p><p><blockquote>截至周日，美国。与冠状病毒相关的死亡人数接近80万。这种新变种促使一些政府官员恢复健康限制以减缓传播。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189054531","content_text":"The S&P 500 was steady on Monday after the index notched its best week since February and a fresh record close, rebounding from a big sell-off triggered by fears of the omicron coronavirus variant.\nThe S&P 500 inched down 0.1% and sits about 0.8% from its intra-day record. The Dow Jones Industrial Average traded 30 points lower, or 0.1%. The technology-focused Nasdaq Composite was down 0.15%.\nModernashares were among the strongest gainers Monday, rising 3% a day after the White House’s top infectious disease expert Dr. Anthony Faucicalled Covid booster shots “optimal care,”but said the definition of fully vaccinated would not change.\nElsewhere,Apple moved closer in its quest to become the market’s first $3 trillion company, gaining about 1% following an upgrade from JP Morgan.\nMonday’s action followed a strong week on Wall Street as investors shrugged off a hot inflation reading. The blue-chip Dow gained 4% last week, breaking a four-week losing streak with its best weekly performance since March. The S&P 500 and the Nasdaq Composite jumped 3.8% and 3.6%, respectively, last week, both posting their best weekly performance since early February.\nInvestors digested a jump in headline inflation data, which came in at 6.8% in November year-over-year for the biggest surge since 1982. The print was marginally higher than the 6.7% Dow Jones estimate.\n“The fact is that inflation is likely to remain on the higher side for a while and risks of sticky inflation remain, although we believe that the passing of base effects and the easing of supply chain constraints by the end of the first quarter of next year should slowly bring inflation down to more comfortable levels,” Rick Rieder, BlackRock’s chief investment officer of global fixed income, said in a note.\nThe key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.\nFed Chair Jerome Powell, as well as a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.\n“We believe markets can continue to take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.\nStocks bounced back last week as investors bet that the initial worry about the Covid strain is overblown. Many also took solace in thenews from Pfizer and BioNTechthat a study found three doses of their vaccine provides a high level of protection against the variant.\nAs of Sunday, the U.S. was approaching 800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":847,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605474279,"gmtCreate":1639235739885,"gmtModify":1639235740030,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605474279","repostId":"2190675480","repostType":4,"isVote":1,"tweetType":1,"viewCount":1155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605875477,"gmtCreate":1639148848235,"gmtModify":1639148893610,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605875477","repostId":"1159401236","repostType":4,"isVote":1,"tweetType":1,"viewCount":767,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602100486,"gmtCreate":1638977487745,"gmtModify":1638977487915,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602100486","repostId":"1105454856","repostType":4,"repost":{"id":"1105454856","kind":"news","pubTimestamp":1638974294,"share":"https://www.laohu8.com/m/news/1105454856?lang=zh_CN&edition=full","pubTime":"2021-12-08 22:38","market":"us","language":"en","title":"From Lucid To ChargePoint -- 3 Renewable Growth Stocks Worth Buying in 2022<blockquote>从Lucid到ChargePoint——2022年值得买入的3只可再生成长股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1105454856","media":"Motley Fool","summary":"A diverse basket of EV and renewable energy stocks built for the long term.","content":"<p>The&nbsp;<b>Nasdaq</b>&nbsp;sell-off is bringing once high-flying names to their knees. From the capitulation of&nbsp;<b>Zoom Video Communications</b>&nbsp;and&nbsp;<b>Teladoc</b>&nbsp;tothe shredding of&nbsp;<b>DocuSign</b>, Wall Street is showing no patience for slowing growth.</p><p><blockquote>The<b>纳斯达克</b>抛售正在让曾经风光无限的公司屈服。从投降开始<b>Zoom Video通信公司</b>和<b>Teladoc</b>粉碎<b>DocuSign</b>，华尔街对增长放缓没有耐心。</blockquote></p><p> <b>Lucid Group</b>,<b>ChargePoint</b>, and&nbsp;<b>TPI Composites</b>&nbsp;are threegrowth stocksthat could all be worth buying for 2022. Here's why.</p><p><blockquote><b>Lucid集团</b>,<b>充电点</b>，和<b>TPI复合材料</b>有三只成长型股票在2022年都值得购买。原因如下。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a3efa3422b14a692649a46d3459f9b66\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> <b>The EV play</b></p><p><blockquote><b>电动汽车游戏</b></blockquote></p><p> Gone are the days of&nbsp;<b>Tesla</b>&nbsp;being the only viable electric vehicle (EV) investment. Today, a growing cohort of up-and-coming names like Lucid,<b>Rivian</b>,and&nbsp;<b>Nio</b>&nbsp;offer different risk-reward profiles. There's also a&nbsp;long list of existing automakers&nbsp;that are investing heavily into EVs, like&nbsp;<b>Ford</b>&nbsp;and&nbsp;<b>General Motors</b>.</p><p><blockquote>的日子一去不复返了<b>特斯拉</b>是唯一可行的电动汽车（EV）投资。如今，越来越多像Lucid这样的后起之秀，<b>Rivian</b>，和<b>蔚来</b>提供不同的风险回报状况。还有一长串现有汽车制造商正在大力投资电动汽车，例如<b>福特</b>和<b>通用汽车</b>.</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2b6df469ef21a76370387705b4b82bf9\" tg-width=\"720\" tg-height=\"533\" width=\"100%\" height=\"auto\"><span>LCID data by YCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCharts提供的LCID数据</span></p></blockquote></p><p> Share prices of Lucid are up over threefold year to date. But even with that rise, the stock could still be a good buy. The key to any new company gaining its footing&nbsp;is establishing a reputation and brand recognition.Lucid takes this task very seriously. It realizes that to&nbsp;compete with existing titans like Tesla, it needs to have something they don't. Its answer: Lucid has packaged together a&nbsp;high-performance, long-range, fast-charging luxury sedan. It's a unique design that doesn't look like a traditional sports car or an executive luxury sedan. Ultimately, investors should go with the EV stock they think has the best chance to succeed. Given its technological edge,Lucid stands out as the best of the bunch. However, the company&nbsp;is facing added uncertainty&nbsp;due to the U.S. Securities and Exchange Commission (SEC) probe that was issued on Dec. 3.</p><p><blockquote>今年迄今为止，Lucid的股价已上涨三倍多。但即使上涨，该股仍然是一个不错的选择。任何新公司站稳脚跟的关键是建立声誉和品牌认知度。Lucid非常认真地对待这项任务。它意识到，要与特斯拉等现有巨头竞争，它需要拥有他们没有的东西。它的答案是：Lucid将一款高性能、远程、快速充电的豪华轿车包装在一起。这是一种独特的设计，看起来不像传统的跑车或行政豪华轿车。最终，投资者应该选择他们认为最有可能成功的电动汽车股票。鉴于其技术优势，Lucid脱颖而出，成为其中的佼佼者。然而，由于美国证券交易委员会(SEC)12月3日发布的调查，该公司面临着更多的不确定性。</blockquote></p><p> <b>The EV charging play</b></p><p><blockquote><b>电动汽车充电游戏</b></blockquote></p><p> Like Lucid, charging infrastructure company ChargePoint is relatively new to the public stage -- having&nbsp;undergone a De-Spac merger&nbsp;earlier this year. 2020 was a tough year for ChargePoint as&nbsp;the company struggled to grow its business. ChargePoint relies on companies and organizations that want to offer EV charging for their employees and customers. With fewer people going to work and shopping in public, the pandemic certainty threw a wrench in ChargePoint's plans. Fast forward to 2021, and&nbsp;ChargePoint has resumed a steady growth trajectory.</p><p><blockquote>与Lucid一样，充电基础设施公司ChargePoint在公共舞台上相对较新——今年早些时候经历了De-Spac合并。2020年对于ChargePoint来说是艰难的一年，该公司努力发展业务。ChargePoint依赖于希望为其员工和客户提供电动汽车充电的公司和组织。随着去公共场所工作和购物的人越来越少，疫情的确定性阻碍了ChargePoint的计划。快进到2021年，ChargePoint恢复了稳定的增长轨迹。</blockquote></p><p> ChargePoint reports its third-quarter 2021 earnings on Tuesday. Industry watchers will likely be listening closely to management's comments on the market outlook as well as how the&nbsp;infrastructure bill&nbsp;affects its business. Either way, ChargePoint is a nice picks and shovels play that should rise along with the EV industry.</p><p><blockquote>ChargePoint周二公布了2021年第三季度收益。行业观察人士可能会密切关注管理层对市场前景的评论以及基础设施法案如何影响其业务。无论哪种方式，ChargePoint都是一个不错的选择和铲子游戏，应该会随着电动汽车行业的发展而崛起。</blockquote></p><p> <b>The wind-energy play</b></p><p><blockquote><b>风能游戏</b></blockquote></p><p> Share prices of independent wind blade manufacturer TPI Composites have gotten absolutely walloped this year. It's been&nbsp;quarter after quarter of disappointing results,too much cash burn, and what looks to be the third straight year of negative earnings. TPI now has a market cap of just $610 million, making it a blip on most renewable energy investors' radar.</p><p><blockquote>独立风力叶片制造商TPI Composites的股价今年遭受重创。一个又一个季度的业绩令人失望，现金消耗过多，而且似乎是连续第三年出现负收益。TPI目前的市值仅为6.1亿美元，这使其成为大多数可再生能源投资者关注的焦点。</blockquote></p><p> Sometimes, when&nbsp;everything is going wrong for a company,it could be a good time to buy. TPI spent the last few years expanding its global manufacturing capacity and building new research centers. It has since struggled to book that added capacity as well as renew contracts on its existing production lines. In sum, TPI is set up nicely for a return to growth in the wind energy space. For investors that believe in the future of wind energy, TPI could be a turnaround play to consider.</p><p><blockquote>有时候，当一家公司一切都出了问题时，这可能是买入的好时机。过去几年，TPI扩大了其全球制造能力并建立了新的研究中心。此后，该公司一直在努力预订增加的产能以及续签现有生产线的合同。总而言之，TPI为风能领域的恢复增长做好了准备。对于相信风能未来的投资者来说，TPI可能是一个值得考虑的扭亏为盈的投资。</blockquote></p><p> <b>Different growth choices</b></p><p><blockquote><b>不同的成长选择</b></blockquote></p><p> Lucid, ChargePoint, and TPI Composites each offer a different way to invest in the energy transition. Lucid is the riskiest of the bunch, as it's a bet on growth in both the EV industry and in demand for Lucid's vehicles. ChargePoint is a simpler choice that depends on public and residential demand for EV charging. TPI Composites expects low growth in 2022 and&nbsp;needs to improve its cash&nbsp;position to weather the expected slowdown in revenue. If it can overcome these challenges, it could rise with the long-term growth in wind-energy installations.</p><p><blockquote>Lucid、ChargePoint和TPI Composites各自提供了不同的能源转型投资方式。Lucid是其中风险最大的，因为它押注于电动汽车行业的增长和对Lucid车辆的需求。ChargePoint是一个更简单的选择，取决于公众和住宅对电动汽车充电的需求。TPI Composites预计2022年增长较低，需要改善现金状况，以应对预期的收入放缓。如果它能够克服这些挑战，它可能会随着风能装机的长期增长而上升。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>From Lucid To ChargePoint -- 3 Renewable Growth Stocks Worth Buying in 2022<blockquote>从Lucid到ChargePoint——2022年值得买入的3只可再生成长股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrom Lucid To ChargePoint -- 3 Renewable Growth Stocks Worth Buying in 2022<blockquote>从Lucid到ChargePoint——2022年值得买入的3只可再生成长股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-08 22:38</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The&nbsp;<b>Nasdaq</b>&nbsp;sell-off is bringing once high-flying names to their knees. From the capitulation of&nbsp;<b>Zoom Video Communications</b>&nbsp;and&nbsp;<b>Teladoc</b>&nbsp;tothe shredding of&nbsp;<b>DocuSign</b>, Wall Street is showing no patience for slowing growth.</p><p><blockquote>The<b>纳斯达克</b>抛售正在让曾经风光无限的公司屈服。从投降开始<b>Zoom Video通信公司</b>和<b>Teladoc</b>粉碎<b>DocuSign</b>，华尔街对增长放缓没有耐心。</blockquote></p><p> <b>Lucid Group</b>,<b>ChargePoint</b>, and&nbsp;<b>TPI Composites</b>&nbsp;are threegrowth stocksthat could all be worth buying for 2022. Here's why.</p><p><blockquote><b>Lucid集团</b>,<b>充电点</b>，和<b>TPI复合材料</b>有三只成长型股票在2022年都值得购买。原因如下。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a3efa3422b14a692649a46d3459f9b66\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> <b>The EV play</b></p><p><blockquote><b>电动汽车游戏</b></blockquote></p><p> Gone are the days of&nbsp;<b>Tesla</b>&nbsp;being the only viable electric vehicle (EV) investment. Today, a growing cohort of up-and-coming names like Lucid,<b>Rivian</b>,and&nbsp;<b>Nio</b>&nbsp;offer different risk-reward profiles. There's also a&nbsp;long list of existing automakers&nbsp;that are investing heavily into EVs, like&nbsp;<b>Ford</b>&nbsp;and&nbsp;<b>General Motors</b>.</p><p><blockquote>的日子一去不复返了<b>特斯拉</b>是唯一可行的电动汽车（EV）投资。如今，越来越多像Lucid这样的后起之秀，<b>Rivian</b>，和<b>蔚来</b>提供不同的风险回报状况。还有一长串现有汽车制造商正在大力投资电动汽车，例如<b>福特</b>和<b>通用汽车</b>.</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2b6df469ef21a76370387705b4b82bf9\" tg-width=\"720\" tg-height=\"533\" width=\"100%\" height=\"auto\"><span>LCID data by YCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCharts提供的LCID数据</span></p></blockquote></p><p> Share prices of Lucid are up over threefold year to date. But even with that rise, the stock could still be a good buy. The key to any new company gaining its footing&nbsp;is establishing a reputation and brand recognition.Lucid takes this task very seriously. It realizes that to&nbsp;compete with existing titans like Tesla, it needs to have something they don't. Its answer: Lucid has packaged together a&nbsp;high-performance, long-range, fast-charging luxury sedan. It's a unique design that doesn't look like a traditional sports car or an executive luxury sedan. Ultimately, investors should go with the EV stock they think has the best chance to succeed. Given its technological edge,Lucid stands out as the best of the bunch. However, the company&nbsp;is facing added uncertainty&nbsp;due to the U.S. Securities and Exchange Commission (SEC) probe that was issued on Dec. 3.</p><p><blockquote>今年迄今为止，Lucid的股价已上涨三倍多。但即使上涨，该股仍然是一个不错的选择。任何新公司站稳脚跟的关键是建立声誉和品牌认知度。Lucid非常认真地对待这项任务。它意识到，要与特斯拉等现有巨头竞争，它需要拥有他们没有的东西。它的答案是：Lucid将一款高性能、远程、快速充电的豪华轿车包装在一起。这是一种独特的设计，看起来不像传统的跑车或行政豪华轿车。最终，投资者应该选择他们认为最有可能成功的电动汽车股票。鉴于其技术优势，Lucid脱颖而出，成为其中的佼佼者。然而，由于美国证券交易委员会(SEC)12月3日发布的调查，该公司面临着更多的不确定性。</blockquote></p><p> <b>The EV charging play</b></p><p><blockquote><b>电动汽车充电游戏</b></blockquote></p><p> Like Lucid, charging infrastructure company ChargePoint is relatively new to the public stage -- having&nbsp;undergone a De-Spac merger&nbsp;earlier this year. 2020 was a tough year for ChargePoint as&nbsp;the company struggled to grow its business. ChargePoint relies on companies and organizations that want to offer EV charging for their employees and customers. With fewer people going to work and shopping in public, the pandemic certainty threw a wrench in ChargePoint's plans. Fast forward to 2021, and&nbsp;ChargePoint has resumed a steady growth trajectory.</p><p><blockquote>与Lucid一样，充电基础设施公司ChargePoint在公共舞台上相对较新——今年早些时候经历了De-Spac合并。2020年对于ChargePoint来说是艰难的一年，该公司努力发展业务。ChargePoint依赖于希望为其员工和客户提供电动汽车充电的公司和组织。随着去公共场所工作和购物的人越来越少，疫情的确定性阻碍了ChargePoint的计划。快进到2021年，ChargePoint恢复了稳定的增长轨迹。</blockquote></p><p> ChargePoint reports its third-quarter 2021 earnings on Tuesday. Industry watchers will likely be listening closely to management's comments on the market outlook as well as how the&nbsp;infrastructure bill&nbsp;affects its business. Either way, ChargePoint is a nice picks and shovels play that should rise along with the EV industry.</p><p><blockquote>ChargePoint周二公布了2021年第三季度收益。行业观察人士可能会密切关注管理层对市场前景的评论以及基础设施法案如何影响其业务。无论哪种方式，ChargePoint都是一个不错的选择和铲子游戏，应该会随着电动汽车行业的发展而崛起。</blockquote></p><p> <b>The wind-energy play</b></p><p><blockquote><b>风能游戏</b></blockquote></p><p> Share prices of independent wind blade manufacturer TPI Composites have gotten absolutely walloped this year. It's been&nbsp;quarter after quarter of disappointing results,too much cash burn, and what looks to be the third straight year of negative earnings. TPI now has a market cap of just $610 million, making it a blip on most renewable energy investors' radar.</p><p><blockquote>独立风力叶片制造商TPI Composites的股价今年遭受重创。一个又一个季度的业绩令人失望，现金消耗过多，而且似乎是连续第三年出现负收益。TPI目前的市值仅为6.1亿美元，这使其成为大多数可再生能源投资者关注的焦点。</blockquote></p><p> Sometimes, when&nbsp;everything is going wrong for a company,it could be a good time to buy. TPI spent the last few years expanding its global manufacturing capacity and building new research centers. It has since struggled to book that added capacity as well as renew contracts on its existing production lines. In sum, TPI is set up nicely for a return to growth in the wind energy space. For investors that believe in the future of wind energy, TPI could be a turnaround play to consider.</p><p><blockquote>有时候，当一家公司一切都出了问题时，这可能是买入的好时机。过去几年，TPI扩大了其全球制造能力并建立了新的研究中心。此后，该公司一直在努力预订增加的产能以及续签现有生产线的合同。总而言之，TPI为风能领域的恢复增长做好了准备。对于相信风能未来的投资者来说，TPI可能是一个值得考虑的扭亏为盈的投资。</blockquote></p><p> <b>Different growth choices</b></p><p><blockquote><b>不同的成长选择</b></blockquote></p><p> Lucid, ChargePoint, and TPI Composites each offer a different way to invest in the energy transition. Lucid is the riskiest of the bunch, as it's a bet on growth in both the EV industry and in demand for Lucid's vehicles. ChargePoint is a simpler choice that depends on public and residential demand for EV charging. TPI Composites expects low growth in 2022 and&nbsp;needs to improve its cash&nbsp;position to weather the expected slowdown in revenue. If it can overcome these challenges, it could rise with the long-term growth in wind-energy installations.</p><p><blockquote>Lucid、ChargePoint和TPI Composites各自提供了不同的能源转型投资方式。Lucid是其中风险最大的，因为它押注于电动汽车行业的增长和对Lucid车辆的需求。ChargePoint是一个更简单的选择，取决于公众和住宅对电动汽车充电的需求。TPI Composites预计2022年增长较低，需要改善现金状况，以应对预期的收入放缓。如果它能够克服这些挑战，它可能会随着风能装机的长期增长而上升。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/08/lucid-to-chargepoint-3-renewable-growth-stocks/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHPT":"ChargePoint Holdings Inc.","LCID":"Lucid Group Inc"},"source_url":"https://www.fool.com/investing/2021/12/08/lucid-to-chargepoint-3-renewable-growth-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105454856","content_text":"The Nasdaq sell-off is bringing once high-flying names to their knees. From the capitulation of Zoom Video Communications and Teladoc tothe shredding of DocuSign, Wall Street is showing no patience for slowing growth.\nLucid Group,ChargePoint, and TPI Composites are threegrowth stocksthat could all be worth buying for 2022. Here's why.\nImage source: Getty Images.\nThe EV play\nGone are the days of Tesla being the only viable electric vehicle (EV) investment. Today, a growing cohort of up-and-coming names like Lucid,Rivian,and Nio offer different risk-reward profiles. There's also a long list of existing automakers that are investing heavily into EVs, like Ford and General Motors.\nLCID data by YCharts\nShare prices of Lucid are up over threefold year to date. But even with that rise, the stock could still be a good buy. The key to any new company gaining its footing is establishing a reputation and brand recognition.Lucid takes this task very seriously. It realizes that to compete with existing titans like Tesla, it needs to have something they don't. Its answer: Lucid has packaged together a high-performance, long-range, fast-charging luxury sedan. It's a unique design that doesn't look like a traditional sports car or an executive luxury sedan. Ultimately, investors should go with the EV stock they think has the best chance to succeed. Given its technological edge,Lucid stands out as the best of the bunch. However, the company is facing added uncertainty due to the U.S. Securities and Exchange Commission (SEC) probe that was issued on Dec. 3.\nThe EV charging play\nLike Lucid, charging infrastructure company ChargePoint is relatively new to the public stage -- having undergone a De-Spac merger earlier this year. 2020 was a tough year for ChargePoint as the company struggled to grow its business. ChargePoint relies on companies and organizations that want to offer EV charging for their employees and customers. With fewer people going to work and shopping in public, the pandemic certainty threw a wrench in ChargePoint's plans. Fast forward to 2021, and ChargePoint has resumed a steady growth trajectory.\nChargePoint reports its third-quarter 2021 earnings on Tuesday. Industry watchers will likely be listening closely to management's comments on the market outlook as well as how the infrastructure bill affects its business. Either way, ChargePoint is a nice picks and shovels play that should rise along with the EV industry.\nThe wind-energy play\nShare prices of independent wind blade manufacturer TPI Composites have gotten absolutely walloped this year. It's been quarter after quarter of disappointing results,too much cash burn, and what looks to be the third straight year of negative earnings. TPI now has a market cap of just $610 million, making it a blip on most renewable energy investors' radar.\nSometimes, when everything is going wrong for a company,it could be a good time to buy. TPI spent the last few years expanding its global manufacturing capacity and building new research centers. It has since struggled to book that added capacity as well as renew contracts on its existing production lines. In sum, TPI is set up nicely for a return to growth in the wind energy space. For investors that believe in the future of wind energy, TPI could be a turnaround play to consider.\nDifferent growth choices\nLucid, ChargePoint, and TPI Composites each offer a different way to invest in the energy transition. Lucid is the riskiest of the bunch, as it's a bet on growth in both the EV industry and in demand for Lucid's vehicles. ChargePoint is a simpler choice that depends on public and residential demand for EV charging. TPI Composites expects low growth in 2022 and needs to improve its cash position to weather the expected slowdown in revenue. If it can overcome these challenges, it could rise with the long-term growth in wind-energy installations.","news_type":1,"symbols_score_info":{"CHPT":0.9,"LCID":0.9,"TPIC":0.9}},"isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606595524,"gmtCreate":1638890598688,"gmtModify":1638890598858,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606595524","repostId":"1142645155","repostType":4,"repost":{"id":"1142645155","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638890012,"share":"https://www.laohu8.com/m/news/1142645155?lang=zh_CN&edition=full","pubTime":"2021-12-07 23:13","market":"us","language":"en","title":"Pinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142645155","media":"Tiger Newspress","summary":"Pinduoduo shares surged 11% in morning trading after Macquarie gave pinduoduo a market beating ratin","content":"<p>Pinduoduo shares surged 11% in morning trading&nbsp;after&nbsp;Macquarie gave pinduoduo a market beating rating with a target price of $95.</p><p><blockquote>麦格理给予拼多多跑赢大盘的评级，目标价95美元后，拼多多股价早盘飙升11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/38c15dca491bd8741f8ac3af099bdeb7\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPinduoduo shares surged 11% in morning trading<blockquote>拼多多股价早盘飙升11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-07 23:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pinduoduo shares surged 11% in morning trading&nbsp;after&nbsp;Macquarie gave pinduoduo a market beating rating with a target price of $95.</p><p><blockquote>麦格理给予拼多多跑赢大盘的评级，目标价95美元后，拼多多股价早盘飙升11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/38c15dca491bd8741f8ac3af099bdeb7\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PDD":"拼多多"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142645155","content_text":"Pinduoduo shares surged 11% in morning trading after Macquarie gave pinduoduo a market beating rating with a target price of $95.","news_type":1,"symbols_score_info":{"PDD":0.9}},"isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606078856,"gmtCreate":1638803847183,"gmtModify":1638803928926,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606078856","repostId":"1172118771","repostType":4,"repost":{"id":"1172118771","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638803122,"share":"https://www.laohu8.com/m/news/1172118771?lang=zh_CN&edition=full","pubTime":"2021-12-06 23:05","market":"us","language":"en","title":"Vaccine stocks mixed in morning trading<blockquote>疫苗股早盘涨跌互现</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172118771","media":"Tiger Newspress","summary":"Vaccine stocks mixed in morning trading.Moderna and BioNTech SE plunged more than 12% while Johnson ","content":"<p>Vaccine&nbsp;stocks&nbsp;mixed&nbsp;in&nbsp;morning&nbsp;trading.Moderna and BioNTech SE plunged more than 12% while Johnson &amp; Johnson and&nbsp;AstraZeneca&nbsp;rose&nbsp;about 2%.</p><p><blockquote>疫苗股早盘涨跌不一，Moderna和BioNTech SE暴跌超12%，强生和阿斯利康涨约2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a026a8b3f73899e06c8e4913061f6618\" tg-width=\"410\" tg-height=\"722\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks mixed in morning trading<blockquote>疫苗股早盘涨跌互现</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks mixed in morning trading<blockquote>疫苗股早盘涨跌互现</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 23:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;mixed&nbsp;in&nbsp;morning&nbsp;trading.Moderna and BioNTech SE plunged more than 12% while Johnson &amp; Johnson and&nbsp;AstraZeneca&nbsp;rose&nbsp;about 2%.</p><p><blockquote>疫苗股早盘涨跌不一，Moderna和BioNTech SE暴跌超12%，强生和阿斯利康涨约2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a026a8b3f73899e06c8e4913061f6618\" tg-width=\"410\" tg-height=\"722\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","GSK":"葛兰素史克","SNY":"赛诺菲安万特","MRNA":"Moderna, Inc.","REGN":"再生元制药公司","PFE":"辉瑞","GILD":"吉利德科学","LLY":"礼来","BNTX":"BioNTech SE","MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172118771","content_text":"Vaccine stocks mixed in morning trading.Moderna and BioNTech SE plunged more than 12% while Johnson & Johnson and AstraZeneca rose about 2%.","news_type":1,"symbols_score_info":{"MRNA":0.9,"SNY":0.9,"GSK":0.9,"PFE":0.9,"REGN":0.9,"MRK":0.9,"BNTX":0.9,"LLY":0.9,"JNJ":0.9,"GILD":0.9}},"isVote":1,"tweetType":1,"viewCount":957,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608659691,"gmtCreate":1638719319240,"gmtModify":1638719319391,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608659691","repostId":"2189576203","repostType":4,"isVote":1,"tweetType":1,"viewCount":793,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608327191,"gmtCreate":1638632558693,"gmtModify":1638632558774,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608327191","repostId":"1174181873","repostType":4,"repost":{"id":"1174181873","kind":"news","pubTimestamp":1638578178,"share":"https://www.laohu8.com/m/news/1174181873?lang=zh_CN&edition=full","pubTime":"2021-12-04 08:36","market":"us","language":"en","title":"US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week<blockquote>美国IPO周：数字银行和云基础设施引领IPO周4</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181873","media":"renaissancecap...","summary":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billi","content":"<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p><p><blockquote>IPO市场预计将在未来一周回暖，预计将有四起IPO筹集37亿美元。</blockquote></p><p> Buffett-backed&nbsp;<b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p><p><blockquote>巴菲特支持<b>Nu控股</b>(NU)计划以411亿美元的市值筹集25亿美元。这家巴西纯在线银行成立于2013年，名为Nubank，旨在推出具有移动优先客户体验的免费信用卡产品，但此后已扩展到提供各种其他金融产品。Nu自成立以来发展迅速，目前拥有近5000万客户群，尽管随着客户群的增长，每个客户的收入一直在下降。</blockquote></p><p> Cloud infrastructure platform&nbsp;<b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&amp;M spend.</p><p><blockquote>云基础设施平台<b>哈希公司</b>(HCP)计划以140亿美元的市值筹集11亿美元。这家风险投资支持的公司提供了一套解决方案，可标准化和自动化大规模云基础设施的配置、保护、连接和运行。尽管HashiCorp表现出快速增长和粘性客户群，但由于S&amp;M支出，HashiCorp非常无利可图。</blockquote></p><p> Cannabis finance REIT&nbsp;<b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p><p><blockquote>大麻金融房地产投资信托基金<b>芝加哥大西洋房地产金融</b>(REFI)计划以2.96亿美元的市值筹集1.06亿美元。这个新成立的房地产投资信托基金专注于发起、构建和投资由商业房地产担保的第一抵押贷款和另类结构性融资。其目前的投资组合包括向大麻行业国家许可运营商提供的高级贷款。</blockquote></p><p> Canadian gold exploration company&nbsp;<b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p><p><blockquote>加拿大黄金勘探公司<b>奥斯汀·戈尔德</b>(AUST)计划以6400万美元的市值筹集1500万美元。这家加拿大黄金勘探公司目前拥有位于内华达州的四处地产的权益，目前只有一处地产被认为是重要的。迄今为止，奥斯汀黄金尚未产生任何营业收入。</blockquote></p><p></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week<blockquote>美国IPO周：数字银行和云基础设施引领IPO周4</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week<blockquote>美国IPO周：数字银行和云基础设施引领IPO周4</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">renaissancecap...</strong><span class=\"h-time small\">2021-12-04 08:36</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p><p><blockquote>IPO市场预计将在未来一周回暖，预计将有四起IPO筹集37亿美元。</blockquote></p><p> Buffett-backed&nbsp;<b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p><p><blockquote>巴菲特支持<b>Nu控股</b>(NU)计划以411亿美元的市值筹集25亿美元。这家巴西纯在线银行成立于2013年，名为Nubank，旨在推出具有移动优先客户体验的免费信用卡产品，但此后已扩展到提供各种其他金融产品。Nu自成立以来发展迅速，目前拥有近5000万客户群，尽管随着客户群的增长，每个客户的收入一直在下降。</blockquote></p><p> Cloud infrastructure platform&nbsp;<b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&amp;M spend.</p><p><blockquote>云基础设施平台<b>哈希公司</b>(HCP)计划以140亿美元的市值筹集11亿美元。这家风险投资支持的公司提供了一套解决方案，可标准化和自动化大规模云基础设施的配置、保护、连接和运行。尽管HashiCorp表现出快速增长和粘性客户群，但由于S&amp;M支出，HashiCorp非常无利可图。</blockquote></p><p> Cannabis finance REIT&nbsp;<b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p><p><blockquote>大麻金融房地产投资信托基金<b>芝加哥大西洋房地产金融</b>(REFI)计划以2.96亿美元的市值筹集1.06亿美元。这个新成立的房地产投资信托基金专注于发起、构建和投资由商业房地产担保的第一抵押贷款和另类结构性融资。其目前的投资组合包括向大麻行业国家许可运营商提供的高级贷款。</blockquote></p><p> Canadian gold exploration company&nbsp;<b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p><p><blockquote>加拿大黄金勘探公司<b>奥斯汀·戈尔德</b>(AUST)计划以6400万美元的市值筹集1500万美元。这家加拿大黄金勘探公司目前拥有位于内华达州的四处地产的权益，目前只有一处地产被认为是重要的。迄今为止，奥斯汀黄金尚未产生任何营业收入。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\">renaissancecap...</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HCP":"HashiCorp, Inc.","NU":"Nu Holdings Ltd.","REFI":"Chicago Atlantic Real Estate Finance, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174181873","content_text":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.\nCloud infrastructure platform HashiCorp(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.\nCannabis finance REIT Chicago Atlantic Real Estate Finance(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.","news_type":1,"symbols_score_info":{"NU":0.9,"HCP":0.9,"REFI":0.9}},"isVote":1,"tweetType":1,"viewCount":1038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601543133,"gmtCreate":1638543984942,"gmtModify":1638543985021,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/601543133","repostId":"2188528084","repostType":4,"isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690218330,"gmtCreate":1639669041402,"gmtModify":1639669041593,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/690218330","repostId":"2191453039","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698938142,"gmtCreate":1640272994312,"gmtModify":1640273005807,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/698938142","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=zh_CN&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19<blockquote>美国将默克药丸作为第二种易于使用的抗COVID-19药物</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">SeattleTimes</strong><span class=\"h-time small\">2021-12-23 22:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p><p><blockquote>美国卫生监管机构周四批准了第二种针对COVID-19的药物，提供了另一种易于使用的药物来对抗不断上升的奥密克戎感染浪潮。</blockquote></p><p> The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p><p><blockquote>美国食品和药物管理局批准默克公司的molnupiravir的一天前，该机构批准了辉瑞公司的一种竞争药物。这种名为Paxlovid的药物很可能成为针对该病毒的首选治疗方法，因为它具有优越的益处和较温和的副作用。</blockquote></p><p> As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p><p><blockquote>因此，默克公司的药物预计对疫情的作用将比几周前预测的要小。它阻止严重新冠肺炎的能力比最初宣布的要小得多，药物标签将警告严重的安全问题，包括潜在的出生缺陷。</blockquote></p><p> The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p><p><blockquote>美国食品和药物管理局批准默克公司的药物用于患有COVID-19早期症状且住院风险最高的成年人，包括老年人以及患有肥胖症和心脏病等疾病的人。英国于11月初首次批准了该药物。</blockquote></p><p> Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p><p><blockquote>默克公司的这种药物被称为molnupiravir，将带有禁止在怀孕期间使用的警告。FDA表示，育龄妇女应在治疗期间和治疗后几天内采取避孕措施，而男性应在最后一次给药后至少三个月内采取避孕措施。</blockquote></p><p> The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p><p><blockquote>FDA顾问小组上个月仅以微弱优势批准了该药物，并警告称其使用必须严格针对能够受益最大的患者，因此这些限制是意料之中的。</blockquote></p><p> The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p><p><blockquote>辉瑞药丸的作用方式不同，也没有同样的风险。此外，辉瑞的药物在测试中的有效性大约是三倍，将高危患者的住院和死亡人数减少了近90%，而默克的药物减少了30%。</blockquote></p><p> Some experts question whether there will be much of a role for the Merck drug in the U.S.</p><p><blockquote>一些专家质疑默克公司的药物在美国是否会发挥很大作用。</blockquote></p><p> “To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p><p><blockquote>梅奥诊所的格雷戈里·波兰博士在谈到默克公司的药物时说：“如果辉瑞公司的药物供应充足，我认为它不会被使用。”“没有理由，因为它的功效较低且副作用风险较高。”</blockquote></p><p> For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p><p><blockquote>目前，FDA的决定为对抗已导致超过80万美国人死亡的病毒提供了另一种潜在选择，尽管卫生官员正在为奥密克戎变种导致的创纪录病例、住院和死亡做好准备。包括默克公司在内的抗病毒药物预计对奥密克戎病毒有效，因为它们不针对该变种大多数令人担忧的突变所在的刺突蛋白。</blockquote></p><p> The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p><p><blockquote>FDA的决定是基于结果显示，近7%服用该药物的患者最终住院，其中一人在30天后死亡。相比之下，服用安慰剂的住院患者比例为10%，死亡人数为9人。</blockquote></p><p> Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p><p><blockquote>联邦官员已同意购买足够治疗310万人的药物。</blockquote></p><p> The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p><p><blockquote>美国将为默克公司的每个疗程支付约700美元，该疗程要求患者每天两次服用四粒药丸，持续五天。哈佛大学和伦敦国王学院的一项审查估计，每个40片疗程的费用约为18美元。</blockquote></p><p> Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p><p><blockquote>默克公司的药物在冠状病毒的遗传密码中插入微小错误，以减缓其繁殖。这种遗传效应引发了人们的担忧，即该药物可能会导致人类胎儿发生突变，甚至刺激更强的病毒株。但FDA科学家表示，变异风险很大程度上是理论上的，因为人们服用这种药物的时间很短。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">SeattleTimes</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":897400937,"gmtCreate":1628952109129,"gmtModify":1633688331794,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/897400937","repostId":"2159321505","repostType":4,"repost":{"id":"2159321505","kind":"highlight","pubTimestamp":1628911811,"share":"https://www.laohu8.com/m/news/2159321505?lang=zh_CN&edition=full","pubTime":"2021-08-14 11:30","market":"us","language":"en","title":"Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2159321505","media":"MarketWatch","summary":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. ","content":"<p>Board members would serve for two years rather than three</p><p><blockquote>董事会成员的任期为两年，而不是三年</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc701f141f0c0044cabe912e510fe2e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Tesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES</span></p><p><blockquote><p class=\"t-img-caption\"><span>特斯拉首席执行官Elon Musk去年在德国。玛雅·希蒂吉/盖蒂图片社</span></p></blockquote></p><p> Tesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.</p><p><blockquote>特斯拉公司在周五晚间提交的文件中表示，该公司将于10月7日在加州弗里蒙特工厂举行股东大会，该公司将提出的提案包括缩短董事任期的看涨期权。</blockquote></p><p> One of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s&nbsp;board currently has nine members who are divided into three classes in staggered three-year terms.</p><p><blockquote>其中一项建议是评级将每名董事的任期从三年减至两年。特斯拉董事会目前有九名成员，分为三类，任期三年。</blockquote></p><p> If the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the&nbsp;filing.</p><p><blockquote>然而，特斯拉在文件中表示，如果该提案获得批准，董事会将分为两个任期交错的类别，董事在两个类别之间的分布尽可能平均。</blockquote></p><p> The board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.</p><p><blockquote>自2007年以来一直在特斯拉董事会任职的风险投资家Antonio Gracias在2019年表示，今年任期结束后，他不会寻求连任，董事会成员将减少至8名。</blockquote></p><p> Tesla’s board nominated current board members James Murdoch, the youngest son of News Corp&nbsp;founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.</p><p><blockquote>特斯拉董事会提名现任董事会成员、新闻集团创始人默多克的小儿子默多克（James Murdoch）和首席执行官马斯克（Elon Musk）的哥哥马斯克（Kimbal Musk）连任二级董事，任期将于2024年届满。该公司表示，如果期限缩减获得批准，那么他们的期限将于2023年结束。</blockquote></p><p> Tesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.</p><p><blockquote>特斯拉缩短董事会成员任期是对股东提议选举每位董事会成员一年的回应。</blockquote></p><p> The two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.</p><p><blockquote>然而，特斯拉表示，两年的任期“在我们股东的长期利益和近期责任之间取得了适当的平衡”。</blockquote></p><p> Tesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&amp;P 500 index.</p><p><blockquote>特斯拉股价在常规交易日收盘下跌0.7%后，在盘后交易中持平。该股今年已上涨1.6%，而标普500指数的涨幅约为19%。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-08-14 11:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Board members would serve for two years rather than three</p><p><blockquote>董事会成员的任期为两年，而不是三年</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc701f141f0c0044cabe912e510fe2e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Tesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES</span></p><p><blockquote><p class=\"t-img-caption\"><span>特斯拉首席执行官Elon Musk去年在德国。玛雅·希蒂吉/盖蒂图片社</span></p></blockquote></p><p> Tesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.</p><p><blockquote>特斯拉公司在周五晚间提交的文件中表示，该公司将于10月7日在加州弗里蒙特工厂举行股东大会，该公司将提出的提案包括缩短董事任期的看涨期权。</blockquote></p><p> One of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s&nbsp;board currently has nine members who are divided into three classes in staggered three-year terms.</p><p><blockquote>其中一项建议是评级将每名董事的任期从三年减至两年。特斯拉董事会目前有九名成员，分为三类，任期三年。</blockquote></p><p> If the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the&nbsp;filing.</p><p><blockquote>然而，特斯拉在文件中表示，如果该提案获得批准，董事会将分为两个任期交错的类别，董事在两个类别之间的分布尽可能平均。</blockquote></p><p> The board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.</p><p><blockquote>自2007年以来一直在特斯拉董事会任职的风险投资家Antonio Gracias在2019年表示，今年任期结束后，他不会寻求连任，董事会成员将减少至8名。</blockquote></p><p> Tesla’s board nominated current board members James Murdoch, the youngest son of News Corp&nbsp;founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.</p><p><blockquote>特斯拉董事会提名现任董事会成员、新闻集团创始人默多克的小儿子默多克（James Murdoch）和首席执行官马斯克（Elon Musk）的哥哥马斯克（Kimbal Musk）连任二级董事，任期将于2024年届满。该公司表示，如果期限缩减获得批准，那么他们的期限将于2023年结束。</blockquote></p><p> Tesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.</p><p><blockquote>特斯拉缩短董事会成员任期是对股东提议选举每位董事会成员一年的回应。</blockquote></p><p> The two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.</p><p><blockquote>然而，特斯拉表示，两年的任期“在我们股东的长期利益和近期责任之间取得了适当的平衡”。</blockquote></p><p> Tesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&amp;P 500 index.</p><p><blockquote>特斯拉股价在常规交易日收盘下跌0.7%后，在盘后交易中持平。该股今年已上涨1.6%，而标普500指数的涨幅约为19%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159321505","content_text":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES\nTesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.\nOne of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s board currently has nine members who are divided into three classes in staggered three-year terms.\nIf the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the filing.\nThe board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.\nTesla’s board nominated current board members James Murdoch, the youngest son of News Corp founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.\nTesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.\nThe two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.\nTesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&P 500 index.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":876576102,"gmtCreate":1637335031179,"gmtModify":1637335033227,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/876576102","repostId":"1112678123","repostType":4,"repost":{"id":"1112678123","kind":"news","pubTimestamp":1637334723,"share":"https://www.laohu8.com/m/news/1112678123?lang=zh_CN&edition=full","pubTime":"2021-11-19 23:12","market":"us","language":"en","title":"Inflation has ‘further to go:’ Goldman Sachs<blockquote>高盛：通胀“还有更长的路要走”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1112678123","media":"Yahoo","summary":"Inflation remains a cause for concern as data continues to butt heads with the White House and the F","content":"<p>Inflation&nbsp;remains a cause for concern as data continues to butt heads with the White House and the Fed’s claim that the price hikes will be “transitory.” According to a Nov. 13 report released by Goldman Sachs Economic Research (GS) however, though inflation has already reached a 30-year high, it may still have more to run.</p><p><blockquote>通胀仍然令人担忧，因为数据继续与白宫和美联储关于物价上涨将是“暂时的”的说法发生冲突。然而，根据高盛经济研究(GS)11月13日发布的报告，尽管通胀已经达到30年来的新高，但可能仍有更多的上涨空间。</blockquote></p><p> “The US economy largely followed the rapid road to recovery that we expected this year and is on track to round out the recovery next year as most of the remaining effects of the pandemic fade,” the report reads. “But this year also brought a major surprise: a surge in inflation that has already reached a 30-year high and still has further to go.”</p><p><blockquote>报告称：“美国经济今年基本上遵循了我们预期的快速复苏之路，随着疫情的大部分剩余影响消退，美国经济有望在明年完成复苏。”“但今年也带来了一个重大惊喜：通胀飙升，已经达到30年来的新高，而且还有很长的路要走。”</blockquote></p><p> The report suggests that this overshoot in inflation is largely attributable to the rise in durable goods prices caused by the persistentsupply chain crunch. Goldman Sachs Economic Research also expects inflationary pressures from wage and rent growth, but this will only keep inflation “moderately above 2%,” in line with the Fed’s updated framework target.</p><p><blockquote>报告表明，通胀超调很大程度上归因于持续的供应链紧缩导致耐用品价格上涨。高盛经济研究还预计，工资和租金增长将带来通胀压力，但这只会使通胀“适度高于2%”，与美联储更新后的框架目标一致。</blockquote></p><p> “The current inflation surge will get worse this winter before it gets better, but as supply-constrained categories shift from a transitory inflationary boost to a transitory deflationary drag, we expect core PCE inflation to fall from 4.4% at end-2021 to 2.3% at end-2022,” the report reads.</p><p><blockquote>“当前的通胀飙升在好转之前将在今年冬天变得更糟，但随着供应受限类别从暂时的通胀提振转变为暂时的通缩拖累，我们预计核心PCE通胀率将从2021年底的4.4%降至2.3%到2022年底，”报告写道。</blockquote></p><p> Goldman also expects the economy to reaccelerate to above a 4% growth rate throughout the next several quarters, citing the reopening of the service sector, consumer spending of pent-up savings, and inventory restocking.</p><p><blockquote>高盛还预计，未来几个季度经济将重新加速至4%以上的增长率，理由是服务业重新开放、消费者支出被压抑的储蓄以及库存补充。</blockquote></p><p> “These forces will contend with a large and steady headwind from diminishing fiscal support that we expect will ultimately leave GDP growth near potential by late 2022,” the report reads.</p><p><blockquote>报告称：“这些力量将应对财政支持减少带来的巨大而稳定的阻力，我们预计到2022年底，GDP增长最终将接近潜力。”</blockquote></p><p> <b>Tapering timeline</b></p><p><blockquote><b>逐渐减少的时间表</b></blockquote></p><p> One of the major implications of these inflation expectations is anupdated timelinefor the Fed’s first rate hikes. The report states that Goldman Sachs would be pulling forward its forecast of the timing of the Fed’s first rate hike to July 2022, shortly after tapering ends.</p><p><blockquote>这些通胀预期的主要影响之一是美联储首次加息的更新时间表。报告指出，高盛将把对美联储首次加息时间的预测提前至2022年7月，即缩减结束后不久。</blockquote></p><p> The FOMC is currently scheduled tocompletethe tapering process by mid-June of 2022. Policymakers will meet next in mid-December where they will submit updated economic forecasts and expected policy paths. In September, around half of policymakers believed that a rate hike would not be necessary until 2023.</p><p><blockquote>FOMC目前计划于2022年6月中旬完成缩减进程。政策制定者将于12月中旬举行下一次会议，届时他们将提交最新的经济预测和预期的政策路径。9月份，大约一半的政策制定者认为，在2023年之前没有必要加息。</blockquote></p><p> “Inflation will have run far above target for a while by then, and we think a seamless move from tapering to rate hikes will be the path of least resistance, with a first hike in July and a second in November,” the report reads. “Because we expect growth and inflation to settle down by year-end without a need for aggressive monetary policy tightening, we have penciled in a slower pace of two hikes per year thereafter.”</p><p><blockquote>报告称：“届时通胀将在一段时间内远高于目标，我们认为从缩减到加息的无缝过渡将是阻力最小的路径，第一次加息将在7月进行，第二次加息将在11月进行。”“由于我们预计经济增长和通胀将在年底前稳定下来，无需大幅收紧货币政策，因此我们预计此后每年加息两次的速度会较慢。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inflation has ‘further to go:’ Goldman Sachs<blockquote>高盛：通胀“还有更长的路要走”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInflation has ‘further to go:’ Goldman Sachs<blockquote>高盛：通胀“还有更长的路要走”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo</strong><span class=\"h-time small\">2021-11-19 23:12</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Inflation&nbsp;remains a cause for concern as data continues to butt heads with the White House and the Fed’s claim that the price hikes will be “transitory.” According to a Nov. 13 report released by Goldman Sachs Economic Research (GS) however, though inflation has already reached a 30-year high, it may still have more to run.</p><p><blockquote>通胀仍然令人担忧，因为数据继续与白宫和美联储关于物价上涨将是“暂时的”的说法发生冲突。然而，根据高盛经济研究(GS)11月13日发布的报告，尽管通胀已经达到30年来的新高，但可能仍有更多的上涨空间。</blockquote></p><p> “The US economy largely followed the rapid road to recovery that we expected this year and is on track to round out the recovery next year as most of the remaining effects of the pandemic fade,” the report reads. “But this year also brought a major surprise: a surge in inflation that has already reached a 30-year high and still has further to go.”</p><p><blockquote>报告称：“美国经济今年基本上遵循了我们预期的快速复苏之路，随着疫情的大部分剩余影响消退，美国经济有望在明年完成复苏。”“但今年也带来了一个重大惊喜：通胀飙升，已经达到30年来的新高，而且还有很长的路要走。”</blockquote></p><p> The report suggests that this overshoot in inflation is largely attributable to the rise in durable goods prices caused by the persistentsupply chain crunch. Goldman Sachs Economic Research also expects inflationary pressures from wage and rent growth, but this will only keep inflation “moderately above 2%,” in line with the Fed’s updated framework target.</p><p><blockquote>报告表明，通胀超调很大程度上归因于持续的供应链紧缩导致耐用品价格上涨。高盛经济研究还预计，工资和租金增长将带来通胀压力，但这只会使通胀“适度高于2%”，与美联储更新后的框架目标一致。</blockquote></p><p> “The current inflation surge will get worse this winter before it gets better, but as supply-constrained categories shift from a transitory inflationary boost to a transitory deflationary drag, we expect core PCE inflation to fall from 4.4% at end-2021 to 2.3% at end-2022,” the report reads.</p><p><blockquote>“当前的通胀飙升在好转之前将在今年冬天变得更糟，但随着供应受限类别从暂时的通胀提振转变为暂时的通缩拖累，我们预计核心PCE通胀率将从2021年底的4.4%降至2.3%到2022年底，”报告写道。</blockquote></p><p> Goldman also expects the economy to reaccelerate to above a 4% growth rate throughout the next several quarters, citing the reopening of the service sector, consumer spending of pent-up savings, and inventory restocking.</p><p><blockquote>高盛还预计，未来几个季度经济将重新加速至4%以上的增长率，理由是服务业重新开放、消费者支出被压抑的储蓄以及库存补充。</blockquote></p><p> “These forces will contend with a large and steady headwind from diminishing fiscal support that we expect will ultimately leave GDP growth near potential by late 2022,” the report reads.</p><p><blockquote>报告称：“这些力量将应对财政支持减少带来的巨大而稳定的阻力，我们预计到2022年底，GDP增长最终将接近潜力。”</blockquote></p><p> <b>Tapering timeline</b></p><p><blockquote><b>逐渐减少的时间表</b></blockquote></p><p> One of the major implications of these inflation expectations is anupdated timelinefor the Fed’s first rate hikes. The report states that Goldman Sachs would be pulling forward its forecast of the timing of the Fed’s first rate hike to July 2022, shortly after tapering ends.</p><p><blockquote>这些通胀预期的主要影响之一是美联储首次加息的更新时间表。报告指出，高盛将把对美联储首次加息时间的预测提前至2022年7月，即缩减结束后不久。</blockquote></p><p> The FOMC is currently scheduled tocompletethe tapering process by mid-June of 2022. Policymakers will meet next in mid-December where they will submit updated economic forecasts and expected policy paths. In September, around half of policymakers believed that a rate hike would not be necessary until 2023.</p><p><blockquote>FOMC目前计划于2022年6月中旬完成缩减进程。政策制定者将于12月中旬举行下一次会议，届时他们将提交最新的经济预测和预期的政策路径。9月份，大约一半的政策制定者认为，在2023年之前没有必要加息。</blockquote></p><p> “Inflation will have run far above target for a while by then, and we think a seamless move from tapering to rate hikes will be the path of least resistance, with a first hike in July and a second in November,” the report reads. “Because we expect growth and inflation to settle down by year-end without a need for aggressive monetary policy tightening, we have penciled in a slower pace of two hikes per year thereafter.”</p><p><blockquote>报告称：“届时通胀将在一段时间内远高于目标，我们认为从缩减到加息的无缝过渡将是阻力最小的路径，第一次加息将在7月进行，第二次加息将在11月进行。”“由于我们预计经济增长和通胀将在年底前稳定下来，无需大幅收紧货币政策，因此我们预计此后每年加息两次的速度会较慢。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/inflation-at-30-year-high-has-further-to-go-goldman-sachs-150441968.html\">Yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://finance.yahoo.com/news/inflation-at-30-year-high-has-further-to-go-goldman-sachs-150441968.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112678123","content_text":"Inflation remains a cause for concern as data continues to butt heads with the White House and the Fed’s claim that the price hikes will be “transitory.” According to a Nov. 13 report released by Goldman Sachs Economic Research (GS) however, though inflation has already reached a 30-year high, it may still have more to run.\n“The US economy largely followed the rapid road to recovery that we expected this year and is on track to round out the recovery next year as most of the remaining effects of the pandemic fade,” the report reads. “But this year also brought a major surprise: a surge in inflation that has already reached a 30-year high and still has further to go.”\nThe report suggests that this overshoot in inflation is largely attributable to the rise in durable goods prices caused by the persistentsupply chain crunch. Goldman Sachs Economic Research also expects inflationary pressures from wage and rent growth, but this will only keep inflation “moderately above 2%,” in line with the Fed’s updated framework target.\n“The current inflation surge will get worse this winter before it gets better, but as supply-constrained categories shift from a transitory inflationary boost to a transitory deflationary drag, we expect core PCE inflation to fall from 4.4% at end-2021 to 2.3% at end-2022,” the report reads.\nGoldman also expects the economy to reaccelerate to above a 4% growth rate throughout the next several quarters, citing the reopening of the service sector, consumer spending of pent-up savings, and inventory restocking.\n“These forces will contend with a large and steady headwind from diminishing fiscal support that we expect will ultimately leave GDP growth near potential by late 2022,” the report reads.\nTapering timeline\nOne of the major implications of these inflation expectations is anupdated timelinefor the Fed’s first rate hikes. The report states that Goldman Sachs would be pulling forward its forecast of the timing of the Fed’s first rate hike to July 2022, shortly after tapering ends.\nThe FOMC is currently scheduled tocompletethe tapering process by mid-June of 2022. Policymakers will meet next in mid-December where they will submit updated economic forecasts and expected policy paths. In September, around half of policymakers believed that a rate hike would not be necessary until 2023.\n“Inflation will have run far above target for a while by then, and we think a seamless move from tapering to rate hikes will be the path of least resistance, with a first hike in July and a second in November,” the report reads. “Because we expect growth and inflation to settle down by year-end without a need for aggressive monetary policy tightening, we have penciled in a slower pace of two hikes per year thereafter.”","news_type":1,"symbols_score_info":{"GS":0.9}},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868970240,"gmtCreate":1632583340080,"gmtModify":1632655091583,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/868970240","repostId":"1149730497","repostType":4,"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":839190420,"gmtCreate":1629125008560,"gmtModify":1633687205228,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/839190420","repostId":"2159248377","repostType":4,"isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":601543133,"gmtCreate":1638543984942,"gmtModify":1638543985021,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/601543133","repostId":"2188528084","repostType":4,"isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826918390,"gmtCreate":1633964147530,"gmtModify":1633964147588,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/826918390","repostId":"2174907652","repostType":4,"isVote":1,"tweetType":1,"viewCount":721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":883396869,"gmtCreate":1631200033251,"gmtModify":1631889986182,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/883396869","repostId":"1109747974","repostType":4,"isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":817686097,"gmtCreate":1630941117619,"gmtModify":1631892482686,"author":{"id":"3585470066266483","authorId":"3585470066266483","name":"PYX","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585470066266483","idStr":"3585470066266483"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/817686097","repostId":"1121396906","repostType":4,"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}